- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03959696
Promoting Informed Decisions About Cancer Screening in Older Adults (PRIMED)
Promoting Informed Decisions About Colorectal Cancer Screening in Older Adults (PRIMED Study): Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maine
-
Portland, Maine, United States, 04102
- Maine Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Danvers, Massachusetts, United States, 01923
- North Shore Medical Center
-
Newton, Massachusetts, United States, 02462
- Newton-Wellesley Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
For Clinicians, eligibility will not be decided by sex, gender, or age
Inclusion Criteria for clinicians:
- Primary Care Physician (MD or NP)
- Manages a panel of patients
- Has ≥20 potentially eligible patients (age 76-85 and due for colorectal cancer screening) in their panel
- Practices at participating site
Exclusion Criteria for clinicians:
- Residents, medical students
- Does not manage panel of patients (e.g. urgent care clinician)
Patients of participating clinicians will be enrolled to evaluate the impact of the interventions.
Inclusion Criteria for patients:
- Adults, age 76-85 at the time of the scheduled visit
- Scheduled for non-urgent office visit with a participating clinician during the study period
- Due or overdue for colorectal cancer screening (e.g. never been screened, 1 year or less to follow-up interval indicated on previous test).
Exclusion Criteria for patients:
- Prior diagnosis of colon or rectal cancer, inflammatory bowel disease or genetic disorder that raises CRC risk (e.g. hereditary non-polyposis CRC and familial adenomatous polyposis)
- Unable to consent for themselves (e.g. moderate to severe dementia or other major cognitive limitations)
- Unable to read or write in English or Spanish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Notification only arm
Clinician participants will be notified of their patients aged 76-85 with an upcoming visit who are due for colorectal cancer screening.
|
Clinicians will be notified of their patients aged 76-85 with an upcoming, non urgent visit who are due for colorectal cancer screening.
|
EXPERIMENTAL: Training and Notification arm
Clinician participants will be notified of their patients aged 76-85 with an upcoming visit who are due for colorectal cancer screening and will complete a two-hour shared decision making communication skills training course that includes case studies, interactive exercises, and lecture content.
|
Clinicians will be notified of their patients aged 76-85 with an upcoming, non urgent visit who are due for colorectal cancer screening.
The 2-hour continuing medical education course in shared decision making, simulated patient interaction to practice skills, and monthly calls for a year to review difficult cases with clinical and shared decision making experts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Shared Decision Making Process (SDMP) Scale Score
Time Frame: 1 week after physician visit
|
The SDM score is generated from the patient responses to the SDM Process survey instrument.
Total scores range from 0-4, with higher scores indicating more shared decision making.
|
1 week after physician visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients' Colorectal Cancer Screening Knowledge Score
Time Frame: 1 week after physician visit
|
Colorectal Cancer (CRC) Screening Knowledge will be assessed with multiple choice knowledge items adapted from the CRC Decision Quality Instrument.
A total score from 0-100% will be calculated based on the number of correct answers, with higher scores indicating higher knowledge.
|
1 week after physician visit
|
Proportion of Patients who received preferred approach to Colorectal Cancer Testing
Time Frame: 1 week after physician visit (preference); 12 months after physician visit (testing)
|
Colorectal Cancer Screening Preference assessed with 1 item adapted from the CRC Decision Quality Instrument will be compared with the screening approach followed (assessed via chart review and patient report) to determine the percentage of patients who received preferred approach to testing.
|
1 week after physician visit (preference); 12 months after physician visit (testing)
|
Physician's shared decision making skills
Time Frame: Baseline
|
The transcripts from the simulated patient interactions will be scored by two coders using Braddock's Informed Decision Making framework.
Total scores range from 0-9 with higher scores indicating more shared decision making in the interaction.
|
Baseline
|
Colorectal cancer screening rates
Time Frame: 1 year
|
The investigators will use established, validated algorithms for calculating cancer screening rates for patients aged 76-85 from a combination of administrative, billing and clinical data.
Data will be aggregated at the physician, practice, and network level to identify the annual rate or percentage of eligible patients up to date for screening during the historical control period and concurrent control observation period both for clinicians enrolled in the study and clinicians not enrolled in the study.
|
1 year
|
Clinician satisfaction with the visit
Time Frame: 1 week post visit
|
The percentage of clinicians who report that they are extremely satisfied with the visit will be compared across arms.
|
1 week post visit
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Caregiver SDM Process Scale score
Time Frame: 1 week after physician visit
|
Caregivers will complete an adapted version of the SDM Process survey to provide different perspective on the conversation and involvement of the patient.
A total score will range from 0-4, with higher scores indicating more shared decision making.
|
1 week after physician visit
|
Clinician attitude toward shared decision making
Time Frame: Baseline
|
The investigators will use five items to assess clinicians' confidence in Shared Decision Making Skills and Barriers to SDM.
A total confidence score (0-20) with higher scores indicating higher confidence and a barrier score (0-8) higher scores indicating more barriers will be calculated.
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Karen R Sepucha, PhD, Harvard Medical School (HMS and HSDM)
- Principal Investigator: Leigh Simmons, MD, Massachusetts General Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018P002848
- CDR-2017C3-9270 (OTHER_GRANT: Patient Centered Outcomes Research Institute (PCORI))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
To promote research replicability, transparency and future use of the data, de-identified data sets of the patient and clinician survey data will be created and will be available, by request, to outside researchers.
After the main manuscripts have been published, de-identified data sets will also be deposited in an open access service such as, ICPSR (https://www.icpsr.umich.edu/icpsrweb/). Before a dataset is made available for access, ICPSR completes a detailed review of all datasets to assess disclosure risk. If necessary, ICPSR modifies data to reduce disclosure risk or limits access to datasets for which modifying the data would substantially limit their utility or the risk of disclosure remains high. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set.
IPD Sharing Time Frame
IPD Sharing Access Criteria
The PI will share a de-identified data set with outside investigators at no cost, according to approved Partners and Massachusetts General Hospital policies for data sharing. Investigators from other sites will be able to request the data and will be required to complete a data use agreement that ensures that all local Institutional Review Board requirements are met before using the data, that they will not attempt to identify any data in the dataset, and that they will not share the data set with anyone outside their project team.
On ICPSR, individuals must register and agree to ICPSR's Responsible Use statement prior to accessing datasets.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer Screening
-
Sunil PatelCompletedColonoscopy | Mass Screening | Colorectal Cancer ScreeningCanada
-
Memorial Sloan Kettering Cancer CenterRalph Lauren Center for Cancer Care and Prevention; North General Hospital,...Completed
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer Screening | Implementation | Colorectal Cancer ScreeningUnited States
-
Motus GI Medical Technologies LtdRecruiting
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingColorectal Cancer | Gastrointestinal Microbiome | Colorectal Polyp | Mass ScreeningChina
-
Massachusetts General HospitalAgency for Healthcare Research and Quality (AHRQ)CompletedBreast Cancer Screening | Colon Cancer Screening | Prostate Cancer ScreeningUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); The Institute for Family HealthEnrolling by invitationColorectal Cancer ScreeningUnited States
-
University Paul Sabatier of ToulouseAssistance Publique Hopitaux De Marseille; Institut National de la Santé Et... and other collaboratorsActive, not recruitingColorectal Cancer ScreeningFrance
-
Florida A&M UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruiting
-
UNC Lineberger Comprehensive Cancer CenterCompletedColorectal Cancer | Colorectal Cancer Screening
Clinical Trials on Notification
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Department...CompletedUpper Gastrointestinal BleedingUnited States
-
Seoul St. Mary's HospitalSaint Vincent's Hospital, Korea; Uijeongbu St. Mary HospitalCompletedColonoscopy | Human CharacteristicsKorea, Republic of
-
Duke UniversityCompletedAdvance Care PlanningUnited States
-
Brigham and Women's HospitalCompletedTest Result ManagementUnited States
-
Columbia UniversityNational Institute of Nursing Research (NINR); Brigham and Women's HospitalCompleted
-
Columbia UniversityCompleted
-
University of North Carolina, Chapel HillCompleted
-
Queen's UniversityHeart and Stroke Foundation of OntarioWithdrawn
-
Icahn School of Medicine at Mount SinaiCompletedAbility to Influence Behavior | Information SystemsUnited States
-
University of WashingtonUniversity of Nairobi; Kenya Ministry of HealthCompleted